Psychemedics Corporation Company Profile (NASDAQ:PMD)

About Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation logoPsychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical & Diagnostic Laboratories
  • Sub-Industry: N/A
  • Symbol: NASDAQ:PMD
  • CUSIP: N/A
  • Web: www.psychemedics.com
Capitalization:
  • Market Cap: $95.39 million
  • Outstanding Shares: 5,491,000
Average Prices:
  • 50 Day Moving Avg: $18.92
  • 200 Day Moving Avg: $21.24
  • 52 Week Range: $13.81 - $27.99
P/E:
  • Trailing P/E Ratio: 12.82
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $42.51 million
  • Price / Sales: 2.22
  • Book Value: $2.99 per share
  • Price / Book: 5.74
Dividend:
  • Annual Dividend: $0.60
  • Dividend Yield: 3.5%
Profitability:
  • EBITDA: $13.84 million
  • Net Margins: 17.59%
  • Return on Equity: 47.94%
  • Return on Assets: 29.82%
Debt:
  • Debt-to-Equity Ratio: 0.06%
  • Current Ratio: 3.00%
  • Quick Ratio: 3.00%
Misc:
  • Average Volume: 42,011 shs.
  • Beta: 1
  • Short Ratio: 0.91
 

Frequently Asked Questions for Psychemedics Corporation (NASDAQ:PMD)

What is Psychemedics Corporation's stock symbol?

Psychemedics Corporation trades on the NASDAQ under the ticker symbol "PMD."

How often does Psychemedics Corporation pay dividends? What is the dividend yield for Psychemedics Corporation?

Psychemedics Corporation declared a quarterly dividend on Thursday, August 3rd. Investors of record on Monday, August 14th will be given a dividend of $0.15 per share on Thursday, August 24th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date is Thursday, August 10th. View Psychemedics Corporation's Dividend History.

How were Psychemedics Corporation's earnings last quarter?

Psychemedics Corporation (NASDAQ:PMD) posted its quarterly earnings results on Wednesday, August, 2nd. The company reported $0.16 earnings per share for the quarter. The firm had revenue of $9.68 million for the quarter. Psychemedics Corporation had a net margin of 17.59% and a return on equity of 47.94%. View Psychemedics Corporation's Earnings History.

When will Psychemedics Corporation make its next earnings announcement?

Psychemedics Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, October, 24th 2017. View Earnings Estimates for Psychemedics Corporation.

Who are some of Psychemedics Corporation's key competitors?

Who are Psychemedics Corporation's key executives?

Psychemedics Corporation's management team includes the folowing people:

  • Raymond C. Kubacki Jr., Chairman of the Board, President, Chief Executive Officer
  • Neil L. Lerner, Vice President - Finance
  • Michael I. Schaffer Ph.D., Vice President - Laboratory Operations
  • A. Clinton Allen, Independent Director
  • Harry F. Connick Sr., Independent Director
  • Walter S. Tomenson Jr., Independent Director
  • Fred J. Weinert, Independent Director

How do I buy Psychemedics Corporation stock?

Shares of Psychemedics Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Psychemedics Corporation's stock price today?

One share of Psychemedics Corporation stock can currently be purchased for approximately $17.15.


MarketBeat Community Rating for Psychemedics Corporation (NASDAQ PMD)
Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  35 (Vote Outperform)
Underperform Votes:  18 (Vote Underperform)
Total Votes:  53
MarketBeat's community ratings are surveys of what our community members think about Psychemedics Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Psychemedics Corporation (NASDAQ:PMD) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Psychemedics Corporation (NASDAQ:PMD)
Price Target History for Psychemedics Corporation (NASDAQ:PMD)
Analysts' Ratings History for Psychemedics Corporation (NASDAQ:PMD)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Psychemedics Corporation (NASDAQ:PMD)
Earnings by Quarter for Psychemedics Corporation (NASDAQ:PMD)
Earnings History by Quarter for Psychemedics Corporation (NASDAQ PMD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2017N/AView Earnings Details
8/2/2017Q2 2017$0.16$9.68 millionViewN/AView Earnings Details
4/25/2017Q1 2017$0.27$10.21 millionViewN/AView Earnings Details
2/10/2015Q414$0.08$0.13$6.80 millionViewN/AView Earnings Details
7/28/2014$0.03$0.16$7.69 millionViewN/AView Earnings Details
4/29/2014Q114$0.12$0.14$6.40 million$7.00 millionViewN/AView Earnings Details
2/10/2014Q4$0.16ViewN/AView Earnings Details
10/28/2013Q313$0.20ViewN/AView Earnings Details
2/25/2013Q4 2012$0.05$5.55 million$5.66 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Psychemedics Corporation (NASDAQ:PMD)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Current Dividend Information for Psychemedics Corporation (NASDAQ:PMD)
Most Recent Dividend:8/24/2017
Annual Dividend:$0.60
Dividend Yield:3.50%
Payout Ratio:44.44% (Trailing 12 Months of Earnings)
Dividend Payments by Quarter for Psychemedics Corporation (NASDAQ:PMD)

Dividend History by Quarter for Psychemedics Corporation (NASDAQ PMD)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/3/2017quarterly$0.152.82%8/10/20178/14/20178/24/2017
4/26/2017quarterly$0.153.08%5/4/20175/8/20175/18/2017
2/6/2017Quarterly$0.152.89%2/14/20172/16/20172/27/2017
10/27/2016quarterly$0.152.62%11/3/201611/7/201611/17/2016
7/27/2016quarterly$0.153.29%8/3/20168/5/20168/15/2016
4/27/2016quarterly$0.154.15%5/4/20165/6/20165/18/2016
2/11/2016quarterly$0.155.75%2/18/20162/22/20163/4/2016
10/29/2015quarterly$0.156.01%11/5/201511/9/201511/19/2015
7/29/2015quarterly$0.155.12%8/5/20158/7/20158/18/2015
4/28/2015quarterly$0.153.71%5/6/20155/8/20155/18/2015
2/11/2015quarterly$0.153.97%2/19/20152/23/20153/6/2015
10/30/2014quarterly$0.154.17%11/6/201411/10/201411/20/2014
10/30/2014quarterly$0.1511/20/201411/10/2014
7/29/2014quarterly$0.154.22%8/5/20148/7/20148/18/2014
4/29/2014quarterly$0.153.81%5/7/20145/9/20145/19/2014
2/10/2014quarterly$0.153.8%2/19/20142/21/20143/7/2014
10/28/2013quarterly$0.154.28%11/6/201311/11/201311/22/2013
8/5/2013quarterly$0.154.68%8/13/20138/15/20138/28/2013
5/7/2013quarterly$0.155.34%5/15/20135/17/20135/30/2013
2/25/2013quarterly$0.154.98%3/5/20133/7/20133/21/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Psychemedics Corporation (NASDAQ:PMD)
Insider Ownership Percentage: 8.60%
Institutional Ownership Percentage: 57.95%
Insider Trades by Quarter for Psychemedics Corporation (NASDAQ:PMD)
Institutional Ownership by Quarter for Psychemedics Corporation (NASDAQ:PMD)
Insider Trades by Quarter for Psychemedics Corporation (NASDAQ:PMD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2017Michael I SchafferVPSell7,548$20.41$154,054.68View SEC Filing  
9/5/2017Michael I SchafferVPSell4,400$20.37$89,628.00View SEC Filing  
9/1/2017Michael I SchafferVPSell981$21.16$20,757.96View SEC Filing  
3/9/2017James V DykeVPSell10,513$20.56$216,147.28View SEC Filing  
12/14/2016James V DykeVPSell5,091$22.83$116,227.53View SEC Filing  
12/9/2016Fred J WeinertDirectorSell4,601$24.45$112,494.45View SEC Filing  
11/18/2016Neil LernerVPSell3,000$24.75$74,250.00View SEC Filing  
11/15/2016James V DykeVPSell10,000$23.56$235,600.00View SEC Filing  
3/2/2016Harry F Sr Connick SrDirectorBuy700$12.83$8,981.00View SEC Filing  
2/26/2016Harry F Sr Connick SrDirectorBuy1,000$12.63$12,630.00View SEC Filing  
2/24/2016Harry F Sr Connick SrDirectorBuy2,000$12.36$24,720.00View SEC Filing  
2/22/2016Harry F Sr Connick SrDirectorBuy1,000$12.61$12,610.00View SEC Filing  
2/19/2016Harry F Sr Connick SrDirectorBuy1,000$11.95$11,950.00View SEC Filing  
2/16/2016Michael I SchafferVPBuy4,507$11.09$49,982.63View SEC Filing  
9/14/2015Raymond C. Kubacki, Jr.CEOBuy2,000$10.12$20,240.00View SEC Filing  
9/10/2015Neil LernerVPBuy3,000$10.32$30,960.00View SEC Filing  
6/16/2015Michael I SchafferVPSell2,837$14.62$41,476.94View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Psychemedics Corporation (NASDAQ:PMD)
Latest Headlines for Psychemedics Corporation (NASDAQ:PMD)
Source:
DateHeadline
finance.yahoo.com logoDoes Psychemedics Corporation’s (PMD) PE Ratio Warrant A Buy?
finance.yahoo.com - October 3 at 10:52 AM
streetinsider.com logoPsychemedics (PMD) Announces Addition of FDA-Cleared Benzodiazepines Hair Test
www.streetinsider.com - September 27 at 11:00 PM
finance.yahoo.com logoPsychemedics Announces Addition of FDA-Cleared Benzodiazepines Hair Test
finance.yahoo.com - September 27 at 11:00 PM
americanbankingnews.com logoInsider Selling: Psychemedics Corporation (PMD) VP Sells 981 Shares of Stock
www.americanbankingnews.com - September 6 at 9:38 PM
americanbankingnews.com logoMichael I. Schaffer Sells 4,400 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 9:16 PM
americanbankingnews.com logoMichael I. Schaffer Sells 7,548 Shares of Psychemedics Corporation (PMD) Stock
www.americanbankingnews.com - September 6 at 8:50 PM
finance.yahoo.com logoETFs with exposure to Psychemedics Corp. : August 21, 2017
finance.yahoo.com - August 22 at 8:29 PM
finance.yahoo.com logoPsychemedics Corporation Launches Synthetic Cannabinoids Hair Test
finance.yahoo.com - August 22 at 3:27 PM
finance.yahoo.com logoPsychemedics Corporation - First Lab Approved For Hair Testing In Iowa
finance.yahoo.com - August 17 at 6:57 AM
finance.yahoo.com logoPsychemedics Corp. :PMD-US: Earnings Analysis: Q2, 2017 By the Numbers : August 9, 2017
finance.yahoo.com - August 10 at 6:58 AM
americanbankingnews.com logoPsychemedics Corporation (NASDAQ:PMD) to Issue $0.15 Quarterly Dividend
www.americanbankingnews.com - August 3 at 6:20 PM
finance.yahoo.com logoPsychemedics Corporation Announces Q2 Earnings
finance.yahoo.com - August 3 at 7:00 AM
finance.yahoo.com logoPsychemedics posts 2Q profit
finance.yahoo.com - August 3 at 7:00 AM
americanbankingnews.com logoPsychemedics Corporation (NASDAQ:PMD) Set to Announce Quarterly Earnings on Monday
www.americanbankingnews.com - July 22 at 10:23 AM
marketbeat.com logoPsychemedics posts 1Q profit
marketbeat.com - April 25 at 5:52 PM
seekingalpha.com logoPsychemedics Corp: It's Not A Short
seekingalpha.com - March 27 at 9:41 AM
seekingalpha.com logoThe Royce Funds: An Analysis Of Particularly Interesting Holdings
seekingalpha.com - March 25 at 8:44 AM
us.rd.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 24 at 7:08 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline - April 3, 2017
us.rd.yahoo.com - March 21 at 10:54 AM
feeds.benzinga.com logoSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Psychemedics Corporation To Contact The Firm Before Lead Plaintiff Deadline
feeds.benzinga.com - March 15 at 9:33 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 15 at 7:27 PM
us.rd.yahoo.com logoDEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact The Firm
us.rd.yahoo.com - March 11 at 2:04 AM
us.rd.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - March 11 at 2:04 AM
biz.yahoo.com logoPSYCHEMEDICS CORP Files SEC form 10-K, Annual Report
biz.yahoo.com - March 7 at 7:08 PM
us.rd.yahoo.com logoPMD SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Psychemedics Corporation and a Lead Plaintiff Deadline of April 3, 2017
us.rd.yahoo.com - February 28 at 7:59 PM
us.rd.yahoo.com logoSHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 28 at 7:59 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 28 at 7:59 PM
us.rd.yahoo.com logoSHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Psychemedics Corporation (PMD) and Lead Plaintiff Deadline: April 3, 2017
us.rd.yahoo.com - February 21 at 5:36 PM
feeds.benzinga.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline – PMD
feeds.benzinga.com - February 17 at 9:51 PM
feeds.benzinga.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation
feeds.benzinga.com - February 17 at 11:12 AM
us.rd.yahoo.com logoGlancy Prongay & Murray Announces the Filing of a Securities Class Action on Behalf of Psychemedics Corporation Investors and Encourages Investors to Contact the Firm
us.rd.yahoo.com - February 15 at 4:36 AM
us.rd.yahoo.com logoINVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
us.rd.yahoo.com - February 15 at 4:36 AM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Files in U.S. District Court to Recover Losses Suffered by Investors in Psychemedics Corporation Sets Lead Plaintiff Deadline of April 3, 2017 -- PMD
us.rd.yahoo.com - February 13 at 11:23 PM
us.rd.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 11 at 1:33 AM
us.rd.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Psychemedics Corporation and Encourages Investors with Losses to Contact the Firm
us.rd.yahoo.com - February 11 at 1:33 AM
us.rd.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Psychemedics Corporation of Class Action Lawsuit and Upcoming Deadline - PMD
us.rd.yahoo.com - February 11 at 1:33 AM
feeds.benzinga.com logoSHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Psychemedics Corporation (PMD) To Contact Brower Piven Before The Lead Plaintiff Deadline
feeds.benzinga.com - February 7 at 2:55 PM
us.rd.yahoo.com logoIMPORTANT EQUITY ALERT: Khang & Khang LLP Announces an Investigation of Psychemedics Corporation and Encourages Investors to Contact the Firm
us.rd.yahoo.com - February 6 at 7:22 PM
us.rd.yahoo.com logoPsychemedics Corporation Announces Record Revenues And Earnings
us.rd.yahoo.com - February 6 at 7:22 PM

Social

Chart

Psychemedics Corporation (PMD) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.